June 14, 2010 Known as EBC-46, the drug may work on a wide-
variety of cancers, including skin, breast, prostate, head and
neck tumors. The drug works by altering white cells to the
growth, which they attack. Despite the promising announcement,
the company's research has yet to be published and human trials
will be necessary to determine the drug efficacy against cancer
in humans. Still according to the Chief Executive of QBiotics,
Dr. Victoria Gordon, the drug proves the importance of
conserving the world rainforests, which are vanishing at a rate
of some 80,000 acres (32,300 hectares) a day. "The world's
rainforests are an amazing biological resource which we need to
conserve and cherish," Gordon said in a statement as reported by
AFP. "Not only may they hold the secret to many new drugs, they
are the home of more than half of all other species with which
we share the planet." Experts say the Earth has entered a mass
extinction period due to human activities, such as deforestation
and habitat destruction. Th